HuGE Literature Finder
Records 1-4
Clinical and mutational profiles of adult medulloblastoma groups.
Acta neuropathologica communications 2020 Nov 8 (1): 191. Wong Gabriel Chun-Hei, Li Kay Ka-Wai, Wang Wei-Wei, Liu Anthony Pak-Yin, Huang Queenie Junqi, Chan Aden Ka-Yin, Poon Manix Fung-Man, Chung Nellie Yuk-Fei, Wong Queenie Hoi-Wing, Chen Hong, Chan Danny Tat Ming, Liu Xian-Zhi, Mao Ying, Zhang Zhen-Yu, Shi Zhi-Feng, Ng Ho-Keu |
CCND2, CTNNB1, DDX3X, GLI2, SMARCA4, MYC, MYCN, PTCH1, TP53, and MLL2 gene variants and risk of childhood medulloblastoma.
Journal of neuro-oncology 2015 Aug . Dahlin Anna M, Hollegaard Mads V, Wibom Carl, Andersson Ulrika, Hougaard David M, Deltour Isabelle, Hjalmars Ulf, Melin Beatri |
Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition.
Cancer cell 2014 Mar 25 (3): 393-405. Kool Marcel, Jones David T W, Jäger Natalie, Northcott Paul A, Pugh Trevor J, Hovestadt Volker, Piro Rosario M, Esparza L Adriana, Markant Shirley L, Remke Marc, Milde Till, Bourdeaut Franck, Ryzhova Marina, Sturm Dominik, Pfaff Elke, Stark Sebastian, Hutter Sonja, Seker-Cin Huriye, Johann Pascal, Bender Sebastian, Schmidt Christin, Rausch Tobias, Shih David, Reimand Jüri, Sieber Laura, Wittmann Andrea, Linke Linda, Witt Hendrik, Weber Ursula D, Zapatka Marc, König Rainer, Beroukhim Rameen, Bergthold Guillaume, van Sluis Peter, Volckmann Richard, Koster Jan, Versteeg Rogier, Schmidt Sabine, Wolf Stephan, Lawerenz Chris, Bartholomae Cynthia C, von Kalle Christof, Unterberg Andreas, Herold-Mende Christel, Hofer Silvia, Kulozik Andreas E, von Deimling Andreas, Scheurlen Wolfram, Felsberg Jörg, Reifenberger Guido, Hasselblatt Martin, Crawford John R, Grant Gerald A, Jabado Nada, Perry Arie, Cowdrey Cynthia, Croul Sydney, Zadeh Gelareh, Korbel Jan O, Doz Francois, Delattre Olivier, Bader Gary D, McCabe Martin G, Collins V Peter, Kieran Mark W, Cho Yoon-Jae, Pomeroy Scott L, Witt Olaf, Brors Benedikt, Taylor Michael D, Schüller Ulrich, Korshunov Andrey, Eils Roland, Wechsler-Reya Robert J, Lichter Peter, Pfister Stefan M, |
TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Dec 28 (35): 5188-96. Pfaff Elke, Remke Marc, Sturm Dominik, Benner Axel, Witt Hendrik, Milde Till, von Bueren André O, Wittmann Andrea, Schöttler Anna, Jorch Norbert, Graf Norbert, Kulozik Andreas E, Witt Olaf, Scheurlen Wolfram, von Deimling Andreas, Rutkowski Stefan, Taylor Michael D, Tabori Uri, Lichter Peter, Korshunov Andrey, Pfister Stefan |
- Page last reviewed:Oct 1, 2020
- Page last updated:Mar 05, 2021
- Content source: